{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:55:12Z","timestamp":1791291312131,"version":"4.3.0"},"reference-count":32,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.8936","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T10:44:59Z","timestamp":1524825899000},"source":"Crossref","is-referenced-by-count":3,"title":["Effects of osteoprotegerin\/TNFRSF11B in two models of abdominal aortic aneurysms"],"prefix":"10.3892","author":[{"given":"Emina","family":"Vorkapic","sequence":"first","affiliation":[{"name":"Division of Drug Research, Department of Medical and Health Sciences, Link\u00ef\u00bf\u00bdping University, 581 85 Link\u00ef\u00bf\u00bdping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kunath","sequence":"additional","affiliation":[{"name":"Division of Drug Research, Department of Medical and Health Sciences, Link\u00ef\u00bf\u00bdping University, 581 85 Link\u00ef\u00bf\u00bdping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"W\u00ef\u00bf\u00bdgs\u00ef\u00bf\u00bdter","sequence":"additional","affiliation":[{"name":"Division of Drug Research, Department of Medical and Health Sciences, Link\u00ef\u00bf\u00bdping University, 581 85 Link\u00ef\u00bf\u00bdping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"key20200713225641_b1-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/pgmj.2008.074666","article-title":"Ruptured abdominal aortic aneurysm: A surgical emergency with many clinical presentations","volume":"85","author":"Assar","year":"2009","journal-title":"Postgrad Med J"},{"key":"key20200713225641_b2-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.carpath.2017.01.008","article-title":"Abdominal aortic aneurysm-an independent disease to atherosclerosis?","volume":"27","author":"Toghill","year":"2017","journal-title":"Cardiovasc Pathol"},{"key":"key20200713225641_b3-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tcm.2005.05.003","article-title":"Local cytokine environments drive aneurysm formation in allografted aortas","volume":"15","author":"Shimizu","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"key20200713225641_b4-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1161\/CIRCULATIONAHA.104.464727","article-title":"Association of osteoprotegerin with human abdominal aortic aneurysm progression","volume":"111","author":"Moran","year":"2005","journal-title":"Circulation"},{"key":"key20200713225641_b5-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1365-2265.2009.03615.x","article-title":"Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm","volume":"72","author":"Moran","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20200713225641_b6-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"key":"key20200713225641_b7-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"key20200713225641_b8-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.277.5327.815","article-title":"An antagonist decoy receptor and a death domain-containing receptor for TRAIL","volume":"277","author":"Pan","year":"1997","journal-title":"Science"},{"key":"key20200713225641_b9-mmr-18-01-0041","first-page":"564934","article-title":"Osteoprotegerin in cardiometabolic disorders","volume":"2015","author":"de Ciriza","year":"2015","journal-title":"Int J Endocrinol"},{"key":"key20200713225641_b10-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"key20200713225641_b11-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"key20200713225641_b12-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"key20200713225641_b13-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/bbrc.2000.4130","article-title":"Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells","volume":"280","author":"Hofbauer","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713225641_b14-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/ATVBAHA.109.199661","article-title":"Biomarkers of the osteoprotegerin pathway: Clinical correlates, subclinical disease, incident cardiovascular disease, and mortality","volume":"30","author":"Lieb","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713225641_b15-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.amjcard.2006.08.064","article-title":"Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)","volume":"99","author":"Abedin","year":"2007","journal-title":"Am J Cardiol"},{"key":"key20200713225641_b16-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"key20200713225641_b17-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1161\/ATVBAHA.111.243592","article-title":"Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease","volume":"32","author":"Koole","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713225641_b18-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: Paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713225641_b19-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","article-title":"Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin","volume":"95","author":"Collin-Osdoby","year":"2004","journal-title":"Circ Res"},{"key":"key20200713225641_b20-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity","volume":"55","author":"Venuraju","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key20200713225641_b21-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1161\/01.ATV.0000236428.91125.e6","article-title":"Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-\/- mice","volume":"26","author":"Bennett","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713225641_b22-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"key20200713225641_b23-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"key20200713225641_b24-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1161\/ATVBAHA.109.188185","article-title":"Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice-brief report","volume":"29","author":"Ovchinnikova","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713225641_b25-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000257339","article-title":"Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo","volume":"47","author":"Candido","year":"2010","journal-title":"J Vasc Res"},{"key":"key20200713225641_b26-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1161\/ATVBAHA.114.304587","article-title":"Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse","volume":"34","author":"Moran","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713225641_b27-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"e0147088","DOI":"10.1371\/journal.pone.0147088","article-title":"Osteoprotegerin prevents development of abdominal aortic aneurysms","volume":"11","author":"Bumdelger","year":"2016","journal-title":"PLoS One"},{"key":"key20200713225641_b28-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.107.707380","article-title":"Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(\u2212\/-) mice","volume":"117","author":"Morony","year":"2008","journal-title":"Circulation"},{"key":"key20200713225641_b29-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1161\/01.CIR.0000038109.84500.1E","article-title":"Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice","volume":"106","author":"M\u00e4ki","year":"2002","journal-title":"Circulation"},{"key":"key20200713225641_b30-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000358920","article-title":"Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-\u03baB ligand and interleukin 6","volume":"51","author":"Callegari","year":"2014","journal-title":"J Vasc Res"},{"key":"key20200713225641_b31-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00125-004-1652-8","article-title":"Arterial osteoprotegerin: Increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha","volume":"48","author":"Olesen","year":"2005","journal-title":"Diabetologia"},{"key":"key20200713225641_b32-mmr-18-01-0041","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0014-5793(02)02872-7","article-title":"PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways","volume":"521","author":"Zhang","year":"2002","journal-title":"FEBS Lett"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:59:10Z","timestamp":1594681150000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.8936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.8936","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}